ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.

Nancy L. Bartlett, Saul A. Rosenberg, Richard T. Hoppe et al. · Journal of Clinical Oncology · 1995 · 204 citations

Medicine, Oncology, Radiation Oncology +16

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

Volker Diehl, Jeremy Franklin, Dirk Hasenclever et al. · Journal of Clinical Oncology · 1998 · 196 citations

Medicine, Oncology, Pharmacotherapy +15

Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492

Sandra J. Horning, Jovanne Williams, Nancy L. Bartlett et al. · Journal of Clinical Oncology · 2000 · 115 citations

Medicine, Oncology, Radiation Oncology +14

Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease.

Paolo G. Gobbi, Carla Pieresca, Maria L. Ghirardelli et al. · PubMed · 1998 · 34 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Can MOPP be replaced in the treatment of advanced Hodgkin's disease?

George P. Canellos · PubMed · 1990 · 20 citations

Medicine, Oncology, Treatment Planning +4